Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;105:787

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Willerson, J. T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Willerson, J. T.

(Circulation. 2002;105:787.)
© 2002 American Heart Association, Inc.


Editorial

Circulation in 2002

James T. Willerson, MD, For the Editors

Early in this new year, the Editors wish to communicate to the readership some of the important goals for Circulation in the immediate future. The past several years have seen substantial changes in Circulation’s publication policies and opportunities for publishing important cardiovascular work. In 1995, Circulation changed from a monthly to a bimonthly publication. In 1999, Circulation became a weekly journal. The rationale for the more frequent publication of Circulation was the Editor’s sense that there should be a journal for cardiovascular work published weekly—one that would communicate the most important advances in both clinical progress and basic discovery as rapidly as possible. At the same time, we committed to relatively rapid review of manuscripts and communication of editorial decisions to authors. In an effort to further accelerate the publication of outstanding work in cardiovascular diseases, Circulation now is committed to the additional developments described below.

We have developed a Rapid Track category for the most important clinical and basic discovery manuscripts submitted to Circulation. On the request of the authors, a full-length manuscript may be accepted as a Rapid Track manuscript when it communicates important discovery, new insight into mechanisms, and/or new treatments for cardiovascular diseases. The manuscript is reviewed within one week, and a decision is communicated immediately to the authors. Accepted manuscripts are published online within 7 to 10 days after corrected proofs are returned from the author and in the print journal in 4 to 5 weeks. The emphasis for these manuscripts is on . . . [Full Text of this Article]